Corcept Therapeutics | Resultat Før Skatt



Pre Tax Profit Endring Dato
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Alaunos Therapeutics USD -7843000 633K 2023-12
ANI Pharmaceuticals USD -13762000 17.74M 2024-12
Ardelyx USD 4.68M 5.45M 2024-12
Aurora Cannabis CAD 32.07M 31.47M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Canopy Growth CAD -121580000 9.67M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
J&J USD 13.63B 8.21B 2025-03
Knight Therapeutics CAD -7144000 19.01M 2024-03
Merck USD 5.22B 114M 2024-12
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Pacira USD 25.53M 24.05M 2024-12
Pfizer USD 4.44B 2.36B 2024-12
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
TG Therapeutics USD 25.45M 21.18M 2024-12



Corcept Therapeutics Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.